Recombinant Human S100A2 Protein，His & GST

S100A2 is a member of the S100 protein family, which plays critical roles in various physiological processes, including cell growth, differentiation, and apoptosis. It is a calcium-binding protein known for its involvement in intracellular signaling pathways and has been linked to several diseases, particularly cancer. Elevated levels of S100A2 have been associated with tumor progression and metastasis, making it a potential biomarker for cancer diagnosis and prognosis. Its expression is often regulated by transcription factors and can vary across different tissue types, which adds complexity to its functional roles. The study of recombinant S100A2 protein allows researchers to explore its structure-function relationship, investigate its biological activities, and develop potential therapeutic applications. Recombinant S100A2 can be produced in various expression systems, enabling the investigation of post-translational modifications and interactions with other proteins. Recent research has focused on understanding how S100A2 influences cellular processes such as migration and invasion, as well as its potential interactions with receptors and other signaling molecules. This knowledge is crucial for developing targeted therapies and improving cancer treatment strategies. Overall, the exploration of S100A2 and its recombinant forms represents a promising avenue for advancing both basic scientific understanding and clinical applications in oncology.